CAROLINE ASAVA: Open Payments
NPI 1336525872 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 43 payments from 9 companies in 2025. Trend: 2023 $534 · 2024 $375 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $392 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $119 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Valinor Pharma, LLC | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Orexo US, Inc. | 2 | $27 |
| SCILEX PHARMACEUTICALS INC. | 1 | $23 |
| MML US, Inc. | 3 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
Products named: QULIPTA, UBRELVY, RELISTOR, BOTOX, XTAMPZA, MOVANTIK, AUSTEDO XR, Zubsolv.
Industry payments across IN — which companies pay providers there.
